BRPI0011152B8 - peptídeos inibidores da exocitose neuronal, mistura de peptídeos, composições cosméticas e farmacêuticas, utilização de um peptídeo, e, método para o tratamento cosmético em um ser humano das rugas faciais e/ou da assimetria facial - Google Patents

peptídeos inibidores da exocitose neuronal, mistura de peptídeos, composições cosméticas e farmacêuticas, utilização de um peptídeo, e, método para o tratamento cosmético em um ser humano das rugas faciais e/ou da assimetria facial

Info

Publication number
BRPI0011152B8
BRPI0011152B8 BRPI0011152A BRPI0011152A BRPI0011152B8 BR PI0011152 B8 BRPI0011152 B8 BR PI0011152B8 BR PI0011152 A BRPI0011152 A BR PI0011152A BR PI0011152 A BRPI0011152 A BR PI0011152A BR PI0011152 B8 BRPI0011152 B8 BR PI0011152B8
Authority
BR
Brazil
Prior art keywords
cosmetic
peptides
facial
peptide
pharmaceutical compositions
Prior art date
Application number
BRPI0011152A
Other languages
English (en)
Inventor
Ferrer Montiel Antonio
Gil Tebar Anabel
Blanes Mira Clara
Perez Paya Enrique
Fernández Ballester Gregorio
Miguel Gutiérrez Perez Luis
Llobregat Hernández Mercedes
Planells Cases Rosa
Viniegra Bover Salvador
Carbonell Castelló Teresa
Original Assignee
Lipotec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8308129&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0011152(B8) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lipotec Sa filed Critical Lipotec Sa
Publication of BRPI0011152B1 publication Critical patent/BRPI0011152B1/pt
Publication of BRPI0011152B8 publication Critical patent/BRPI0011152B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurosurgery (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Cell Biology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Ophthalmology & Optometry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

"péptidos inibidores da exocitosis neurónica, composições cosméticas e farmacêuticas que os contêm". o péptido tem uma sequência de 3 a 30 amino-ácidos contíguos procedentes do extremo amino da proteína snap-25 e é útil como inibidor da exocitosis neurónica. as composições cosméticas e farmacêuticas compreendem o mencionado péptido, opcionalmente junto com um ou mais péptidos procedentes do extremo carboxilo da snap-25. as composições são adequadas para o tratamento das rugas faciais, da assimetria facial e de transtornos e alterações patológicas mediadas por uma exócitosis neurónica patológica.
BRPI0011152A 1999-04-23 2000-02-18 peptídeos inibidores da exocitose neuronal, mistura de peptídeos, composições cosméticas e farmacêuticas, utilização de um peptídeo, e, método para o tratamento cosmético em um ser humano das rugas faciais e/ou da assimetria facial BRPI0011152B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES009900844A ES2160485B1 (es) 1999-04-23 1999-04-23 Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
ESP9900844 1999-04-23
PCT/ES2000/000058 WO2000064932A1 (es) 1999-04-23 2000-02-18 Peptitos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen

Publications (2)

Publication Number Publication Date
BRPI0011152B1 BRPI0011152B1 (pt) 2018-03-13
BRPI0011152B8 true BRPI0011152B8 (pt) 2022-05-10

Family

ID=8308129

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0011152A BRPI0011152B8 (pt) 1999-04-23 2000-02-18 peptídeos inibidores da exocitose neuronal, mistura de peptídeos, composições cosméticas e farmacêuticas, utilização de um peptídeo, e, método para o tratamento cosmético em um ser humano das rugas faciais e/ou da assimetria facial
BR0011152-0A BR0011152A (pt) 1999-04-23 2000-02-18 Péptidos inibidores da exocitosis neurónica, composições cosméticas e farmacêuticas que os contêm

Family Applications After (1)

Application Number Title Priority Date Filing Date
BR0011152-0A BR0011152A (pt) 1999-04-23 2000-02-18 Péptidos inibidores da exocitosis neurónica, composições cosméticas e farmacêuticas que os contêm

Country Status (12)

Country Link
US (2) US7015192B1 (pt)
EP (1) EP1180524B2 (pt)
JP (2) JP4363556B2 (pt)
AT (1) ATE338062T1 (pt)
AU (1) AU2672900A (pt)
BR (2) BRPI0011152B8 (pt)
CA (1) CA2370289C (pt)
DE (1) DE60030429T3 (pt)
DK (1) DK1180524T4 (pt)
ES (1) ES2160485B1 (pt)
PT (1) PT1180524E (pt)
WO (1) WO2000064932A1 (pt)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2160485B1 (es) * 1999-04-23 2002-05-16 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.
EP1301213B1 (en) 2000-07-21 2017-01-18 ReVance Therapeutics, Inc. Multi-component biological transport systems
US7332567B2 (en) * 2001-08-28 2008-02-19 Allergan, Inc. Fret protease assays for clostridial toxins
FR2846885B1 (fr) * 2002-11-13 2004-12-24 Oreal Utilisation d'une association de composants a effet synergique inhibiteur de canaux calciques pour prevenir ou traiter les ridules
US7071167B2 (en) 2002-11-13 2006-07-04 L'oreal Use of a combination of components with an inhibitory synergistic effect on calcium channels to prevent or treat wrinkles and fine lines
JP2004323400A (ja) * 2003-04-23 2004-11-18 Mikimoto Pharmaceut Co Ltd 皮膚外用剤
CA2558676C (en) 2004-03-03 2019-04-16 Essentia Biosystems, Inc. Compositions and methods for topical diagnostic and therapeutic transport
US9211248B2 (en) 2004-03-03 2015-12-15 Revance Therapeutics, Inc. Compositions and methods for topical application and transdermal delivery of botulinum toxins
CN1946431B (zh) 2004-03-03 2011-12-07 雷文斯治疗公司 用于肉毒毒素的局部施用和透皮递送的组合物和方法
US20060073208A1 (en) 2004-10-01 2006-04-06 Allergan, Inc. Cosmetic neurotoxin compositions and methods
CA2584643C (en) * 2004-11-02 2013-01-29 Pentapharm Ag New, topically applicable actives against mimic and age-related wrinkles
SG160357A1 (en) 2005-03-03 2010-04-29 Revance Therapeutics Inc Compositions and methods for topical application and transdermal delivery of botulinum toxins
CN101160318A (zh) 2005-03-03 2008-04-09 雷文斯治疗公司 用于局部施用和经皮肤递送寡肽的组合物和方法
ES2259928B1 (es) * 2005-04-08 2007-11-01 Lipotec, S.A. Composicion cosmetica o dermofarmaceutica que comprende peptidos derivados de encefalinas para reducir y/o eliminar arrugas faciales.
NZ568216A (en) 2005-11-17 2012-09-28 Revance Therapeutics Inc Compositions and methods of topical application and transdermal delivery of botulinum toxins with reduced non-toxin proteins
WO2007071448A2 (en) * 2005-12-23 2007-06-28 Partnership & Corp. Technology Transfer Synthetic peptides for use as inhibitors of neurotransmitter secretion and as inducers of muscle relaxation
ES2322882B1 (es) * 2006-10-25 2010-04-22 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal.
EP1992332A1 (en) * 2007-05-08 2008-11-19 Tupperware Products S.A. Cosmetic anti ageing skin care compositions
ES2356883B1 (es) * 2008-07-24 2012-02-22 Bcn Peptides, S.A. Composición para el tratamiento del dolor y/o la inflamación.
JP5782439B2 (ja) * 2009-07-24 2015-09-24 リポテック, エセ.ア.Lipotec, S.A. 筋肉収縮を抑制する化合物
US20130078295A1 (en) * 2010-06-09 2013-03-28 Lipotec S.A. Skin antiaging treatment
US20110305735A1 (en) * 2010-06-09 2011-12-15 Lipotec, S.A. Skin antiaging treatment
ES2385683B1 (es) * 2010-10-18 2013-10-07 Bcn Peptides, S.A. Composiciones para el tratamiento del dolor y/o la inflamación.
WO2013070808A1 (en) * 2011-11-07 2013-05-16 Feng Tian Peptide-based compounds as inhibitors of neurotransmitter secretion
ES2424294B1 (es) 2012-03-22 2014-07-21 Lipotec, S.A. Exopolisacárido para el tratamiento y/o cuidado de la piel, mucosas, cabello y/o uñas
US10149812B2 (en) 2012-04-13 2018-12-11 Activen Cosmetic composition comprising a muconopeptide
EP2649983A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (II)
WO2013153236A2 (en) 2012-04-13 2013-10-17 Activen Cosmetic composition comprising a muconopeptide
EP2836193B1 (en) 2012-04-13 2018-01-31 Lubrizol Advanced Materials, Inc. Compounds which inhibit neuronal exocytosis (ii)
EP2649985A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis (III)
EP2649984A1 (en) 2012-04-13 2013-10-16 Lipotec, S.A. Compounds which inhibit neuronal exocytosis
WO2015063613A2 (en) 2013-11-01 2015-05-07 Spherium Biomed S.L. Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
MX394677B (es) 2014-10-31 2025-03-24 Lubrizol Advanced Mat Inc Pelicula de poliuretano termoplastico para la liberacion de agentes activos a superficies de piel.
CN104478991B (zh) * 2014-12-10 2018-06-19 深圳市维琪医药研发有限公司 一种新型多肽化合物及其制备方法和其医药应用
CN104829691B (zh) * 2015-05-19 2018-11-02 山西锦波生物医药股份有限公司 除皱短肽及其制备方法
US20180311358A1 (en) 2015-11-05 2018-11-01 Lubrizol Advanced Materials, Inc. Thermoformable dual network hydrogel compositions
ES2937382T3 (es) 2018-02-27 2023-03-28 Lipotrue S L Péptidos y composiciones para uso en cosmética y medicina
WO2019238683A1 (en) 2018-06-13 2019-12-19 Aziende Chimiche Riunite Angelini Francesco - A.C.R.A.F. S.P.A. Peptides having inhibitory activity on neuronal exocytosis
EP3833674A1 (en) 2018-08-10 2021-06-16 Lubrizol Advanced Materials, Inc. Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes
JP2022514114A (ja) 2018-10-16 2022-02-09 ジーエルオー ファーマ，インク． ニコチン性アセチルコリン受容体ペプチドアンタゴニストであるコノトキシン組成物、およびこれに関連する方法
MX2020014330A (es) * 2018-12-26 2021-03-09 Caregen Co Ltd Composicion para relajacion muscular.
EP4144337B1 (en) 2021-09-02 2024-08-07 Guangzhou Jiyan Cosmetics Technology Co. Ltd. Vitis vinifera cosmetic composition
CN113826764B (zh) * 2021-09-24 2024-07-12 江苏三仪生物工程有限公司 一种大豆小肽螯合铁的制备方法
EP4230638A1 (en) 2022-02-16 2023-08-23 Lipotrue, S.L. Peptides and compositions for use in cosmetics
US20250161409A1 (en) 2022-02-23 2025-05-22 Prospera Biotech, S.L. Compositions for treating hyperhidrosis
CN117203217B (zh) 2022-03-28 2024-11-29 深圳市维琪科技股份有限公司 一种多肽及其组合物和用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6169074B1 (en) * 1996-03-18 2001-01-02 The Regents Of The University Of California Peptide inhibitors of neurotransmitter secretion by neuronal cells
ES2160485B1 (es) * 1999-04-23 2002-05-16 Lipotec Sa Peptidos inhibidores de la exocitosis neuronal, composiciones cosmeticas y farmaceuticas que los contienen.

Also Published As

Publication number Publication date
CA2370289C (en) 2011-04-19
DE60030429D1 (de) 2006-10-12
EP1180524A1 (en) 2002-02-20
BR0011152A (pt) 2002-02-19
ES2160485B1 (es) 2002-05-16
EP1180524B1 (en) 2006-08-30
DE60030429T3 (de) 2012-01-12
WO2000064932A1 (es) 2000-11-02
BRPI0011152B1 (pt) 2018-03-13
DK1180524T3 (da) 2006-12-11
JP2002542777A (ja) 2002-12-17
EP1180524B2 (en) 2010-07-07
JP4363556B2 (ja) 2009-11-11
US20060276392A1 (en) 2006-12-07
US7473679B2 (en) 2009-01-06
JP4892037B2 (ja) 2012-03-07
DK1180524T4 (da) 2010-10-25
JP2009221223A (ja) 2009-10-01
ATE338062T1 (de) 2006-09-15
CA2370289A1 (en) 2000-11-02
US7015192B1 (en) 2006-03-21
DE60030429T2 (de) 2007-10-31
AU2672900A (en) 2000-11-10
ES2160485A1 (es) 2001-11-01
PT1180524E (pt) 2007-01-31

Similar Documents

Publication Publication Date Title
BRPI0011152B8 (pt) peptídeos inibidores da exocitose neuronal, mistura de peptídeos, composições cosméticas e farmacêuticas, utilização de um peptídeo, e, método para o tratamento cosmético em um ser humano das rugas faciais e/ou da assimetria facial
Wang et al. Bioavailability and bioavailable forms of collagen after oral administration to rats
Wilkinson Troponin C from rabbit slow skeletal and cardiac muscle is the product of a single gene
CN104968360B (zh) 用于治疗和/或护理皮肤、毛发和/或粘膜的化合物以及它们的化妆美容或药物组合物
DE69326064D1 (de) Peptide des menschlichen Proteins P53 zum Gebrauch in menschlichen-zytotoxischen-T-Zell-Antwort-induzierenden Kompositionen sowie menschliche P53-Protein-spezifische T-Lymphocyten
PT883687E (pt) Receptores de quimiocinas c-c, ckr-5, cc, os seus derivados e as suas utilizacoes
DE69912870D1 (de) Kosmetische oder dermatologische Zusammensetzung, enthaltend zumindest ein natürliches oder rekombinantes Seidenprotein von Arachniden oder ein analoges Protein
BR9807673A (pt) Processos para tratar asma alérgica e dermatite em um humano e composição farmacêutica.
CN102958503A (zh) Sirtuin 6激活肽以及包含所述激活肽的化妆品或药物组合物
DE69719754D1 (de) Therapeutische verwendungen von bpi-protein produkten bei menschen mit durch trauma verursachter blutung
ES2052583T3 (es) Derivados de peptidos relacionados con el gel calcitonina.
AR002742A1 (es) Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn
Gildberg et al. Angiotensin I-converting enzyme inhibitory activity in a hydrolysate of proteins from Northern shrimp (Pandalus borealis) and identification of two novel inhibitory tri-peptides
ATE485377T1 (de) Das überleben dopaminerger neuronen fördernde faktoren und deren verwendungen
FI964186A0 (fi) Ei-liittävät gp350/220-variantit
DK0707473T3 (da) Orale farmaceutiske præparater omfattende et protein eller et peptid, et antistof og polymerkugler
BR9712128A (pt) Métodos e composições para lipidização de moléculas hidrofìlicas
Fujitani et al. Nonhistone nuclear proteins of rat brain
BR9612422A (pt) Pseudo-partìculas virais recombinantes, composição, utilização de pseudo-partìculas, e, processo de estimulação in vitro de respostas t citotóxicas de linfócitos provenientes de indivìduos atingidos por infecções virais ou tumorais.
FR2569111B1 (fr) Nouveaux medicaments contenant des tripeptides
BRPI0408244A (pt) composição de cuidado pessoal, e, processo para fabricar uma composição de cuidado pessoal
BR0014803A (pt) Peptìdeo, composição farmacêutica, uso de um ou mais dos peptìdeos, e, composição de diagnóstico
PT990000E (pt) Factor 3 de crescimento do tecido conjuntivo
BR0308978A (pt) fragmentos de peptìdeos sintéticos ativos
BR9808866A (pt) Moléculas retinóicas relacionadas à inibição da superprodução de endotelina-1 em doenças